| 摘要 |
<p>The present invention relates to a pharmaceutical composition comprising anti-CXCL2 or anti-CXCR2 monoclonal antibody for preventing or treating a graft-versus-host disease. The pharmaceutical composition according to the present invention prevents the graft-versus-host disease and enhances anti-tumor effect by relatively promoting movement of cancer cells by interfering with T-cells from accessing a target organ of the graft-versus-host disease.</p> |
